ARROWHEAD PHARMACEUTICALS, INC. Insider Trading for January 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARROWHEAD PHARMACEUTICALS, INC. for January 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Grant | A | 0.00 | 25,000 | 0 | 73,852 | 48.9 K to 73.9 K (+51.17 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | PERRY MICHAEL S | Director | Grant | A | 0.00 | 30,000 | 0 | 75,000 | 45 K to 75 K (+66.67 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Grant | A | 0.00 | 35,000 | 0 | 90,000 | 55 K to 90 K (+63.64 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Leone Peter Brian | VP, Strategy & Prog ... | Option Exercise | A | 6.15 | 50,000 | 307,500 | 220,000 | |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Option Exercise | A | 6.15 | 60,000 | 369,000 | 150,000 | |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Option Exercise | A | 6.15 | 85,000 | 522,750 | 472,500 | |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | A | 6.15 | 60,000 | 369,000 | 556,000 | |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Grant | A | 0.00 | 150,000 | 0 | 425,000 | 275 K to 425 K (+54.55 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | A | 6.15 | 40,000 | 246,000 | 362,000 | |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 135,000 | 85 K to 135 K (+58.82 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 6.13 | 23,347 | 143,117 | 85,000 | 108.3 K to 85 K (-21.55 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Payment of Exercise | F | 6.13 | 13,153 | 80,628 | 108,347 | 121.5 K to 108.3 K (-10.83 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | A | 6.15 | 80,000 | 492,000 | 1,166,466 | |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Grant | A | 0.00 | 540,000 | 0 | 1,101,461 | 561.5 K to 1.1 M (+96.18 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Payment of Exercise | F | 6.13 | 58,712 | 359,905 | 561,461 | 620.2 K to 561.5 K (-9.47 %) |